News

Attending the 2019 ASM Microbe in San Francisco, CA

“Supporting the development of novel antimicrobials in a post-antibiotic era.” Alameda, CA – Emery Pharma will attend the 2019 American Society for Microbiology (ASM) Microbe Conference, held on June 20…

Read More

Emery Pharma FDA Investigation Results

ALAMEDA, CA. – Today Emery Pharma has announced that on November 13th to 16th, 2018, FDA inspectors conducted a 4-day, unannounced, general inspection of our laboratory facility in Alameda, CA ….

Read More

Attending 2019 J.P. Morgan 37th Annual Healthcare Conference

ALAMEDA, CA. – Today Emery Pharma has announced that Ron Najafi, Ph.D., CEO of Emery Pharma, will be available to during the JP Morgan Annual Healthcare Conference, held on January 7…

Read More

cGMP-GLP NMR capabilities highlighted at 2018 AAPS

Alameda, CA – Ron Najafi, Ph.D., CEO and founder of Emery Pharma, and Neeku Mahdavian, Business Development Manager of Emery Pharma, will be attending the 2018 American Association of Pharmaceutical Scientists…

Read More

Attending Outsourced Pharma Conference and Exhibition in San Francisco on October 29-30th 2018

Click the picture above to register using promo code EMERY for a FREE pass courtesy of Emery Pharma Alameda, CA – Join Ron Najafi, Ph.D., CEO and founder of Emery Pharma,…

Read More

Emery Pharma and CP Lab Safety to Exhibit ACS 2018 Boston

Boston, MA: Emery Pharma’s CEO Dr. Ron Najafi and CP Lab Safety’s CEO Kelly Farhangi and will be attending the American Chemical Society’s (ACS) National Expo in Boston, Massachusetts August 19 –…

Read More

Our Values and Mission: Emery Pharma Gives Back

On July 10, 2018, Emery Pharma and CP Lab Safety, teamed up to do a beach cleanup hosted by Golden Gate National Parks Volunteer Program. The program is a collaborative…

Read More

Comparative Evaluation of Biomed InTray® Colorex MRSA device with BD ESwab Collection Kit/ BBL™ CHROMagar® MRSA II

Emery Pharma scientists worked with Biomed comparing their InTray® MRSA selective agar product to current market MRSA selective agars in order to evaluate diagnostic efficacy. From this research they then…

Read More

More Diagnostics, Inc. Signs an Agreement with Emery Pharma

LOS OSOS, Calif., April 11, 2018 /PRNewswire/ — More Diagnostics, Inc., an employee owned developer and manufacturer of clinical diagnostic controls and Emery Pharma, a full-service contract research & development…

Read More

Emery Pharma and CP Lab Safety to Exhibit at 2018 R. Bryan Miller Symposium

Davis, CA: Emery Pharma, a full-service contract research laboratory, and CP Lab Safety, a woman owned, recipient of environmental sustainability award by congressman Jared Huffman, California Certified Small Business and…

Read More